Alterity Therapeutics Limited
ATH
Rank in Stocks
#25472
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Share Price
$0.21511186
Last synced: 2026-10-16
Market Cap
$47.00M
Change (1 day)
0.00%
Change (1 year)
-38.54%
Country
AU
Trade Alterity Therapeutics Limited (ATH)
Category
Healthcare
Market Capitalization of Alterity Therapeutics Limited(ATH)
Market Cap: $47.00M
As of October 2026 Alterity Therapeutics Limited has a market cap of $47.00M. This makes Alterity Therapeutics Limited the world's 25472nd most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Alterity Therapeutics Limited from 2012 to 2026
ATH compared with Top 5 Most Popular stocks
